Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmet B Gungor

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 8, 2026
Unintended Consequences of the Kidney Safety Net Policy: A Call for Refined Eligibility CriteriaVenkatesh K Ariyamuthu, Ahmet B Gungor, Bekir Tanriover
Current Opinion in Organ Transplantation|October 13, 2022
Utilization of hepatitis C virus-positive donors in kidney transplantationAneesha Shetty, Venkatesh K Ariyamuthu, Ahmet B Gungor, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 10, 2022
Outcomes of Simultaneous Liver-Kidney Transplantation Using Kidneys of Deceased Donors With Acute Kidney InjuryRamesh K Batra, Venkatesh K Ariyamuthu, Malcolm P MacConmara, et al.
The American Journal of Medicine|October 1, 2022
The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab-Cilgavimab (Evusheld): Real-World Experience at a Large Academic CenterMohanad M Al-Obaidi, Ahmet B Gungor, Sandra E Kurtin, et al.
The American Journal of Medicine|March 10, 2023
The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant EraMohanad M Al-Obaidi, Ahmet B Gungor, Sangeetha Murugapandian, et al.
Plos One|April 28, 2023
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated eraSrilekha Sridhara, Ahmet B Gungor, Halil K Erol, et al.
Transplantation|March 12, 2025
The Final Rule in a Bind: What We Are Learning From Suboptimal Simultaneous Heart-Kidney Outcomes and Potential Solutions to the ProblemVenkatesh K Ariyamuthu, Xingxing S Cheng, Benjamin Hippen, et al.
Transplantation|July 24, 2025
"The Final Rule in a Bind: What We Are Learning From Suboptimal Simultaneous Heart-Kidney Outcomes and Potential Solutions to the Problem": ErratumVenkatesh K Ariyamuthu, Xingxing S Cheng, Benjamin Hippen, et al.
Open Forum Infectious Diseases|July 6, 2022
Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) InfectionMohanad M Al-Obaidi, Ahmet B Gungor, Saman Nematollahi, et al.
Kidney International Reports|January 16, 2026
Predicting Simultaneous Heart Kidney Allocation and Posttransplant Adverse Kidney OutcomesMutlu Mete, Mehmet U S Ayvaci, Ahmet B Gungor, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 8, 2026
Unintended Consequences of the Kidney Safety Net Policy: A Call for Refined Eligibility CriteriaVenkatesh K Ariyamuthu, Ahmet B Gungor, Bekir Tanriover
Current Opinion in Organ Transplantation|October 13, 2022
Utilization of hepatitis C virus-positive donors in kidney transplantationAneesha Shetty, Venkatesh K Ariyamuthu, Ahmet B Gungor, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 10, 2022
Outcomes of Simultaneous Liver-Kidney Transplantation Using Kidneys of Deceased Donors With Acute Kidney InjuryRamesh K Batra, Venkatesh K Ariyamuthu, Malcolm P MacConmara, et al.
The American Journal of Medicine|October 1, 2022
The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab-Cilgavimab (Evusheld): Real-World Experience at a Large Academic CenterMohanad M Al-Obaidi, Ahmet B Gungor, Sandra E Kurtin, et al.
The American Journal of Medicine|March 10, 2023
The Impact of Nirmatrelvir-Ritonavir in Reducing Hospitalizations Among High-Risk Patients With SARS-CoV-2 During the Omicron Predominant EraMohanad M Al-Obaidi, Ahmet B Gungor, Sangeetha Murugapandian, et al.
Plos One|April 28, 2023
Lack of effectiveness of Bebtelovimab monoclonal antibody among high-risk patients with SARS-Cov-2 Omicron during BA.2, BA.2.12.1 and BA.5 subvariants dominated eraSrilekha Sridhara, Ahmet B Gungor, Halil K Erol, et al.
Transplantation|March 12, 2025
The Final Rule in a Bind: What We Are Learning From Suboptimal Simultaneous Heart-Kidney Outcomes and Potential Solutions to the ProblemVenkatesh K Ariyamuthu, Xingxing S Cheng, Benjamin Hippen, et al.
Transplantation|July 24, 2025
"The Final Rule in a Bind: What We Are Learning From Suboptimal Simultaneous Heart-Kidney Outcomes and Potential Solutions to the Problem": ErratumVenkatesh K Ariyamuthu, Xingxing S Cheng, Benjamin Hippen, et al.
Open Forum Infectious Diseases|July 6, 2022
Effectiveness of Casirivimab-Imdevimab Monoclonal Antibody Treatment Among High-Risk Patients With Severe Acute Respiratory Syndrome Coronavirus 2 B.1.617.2 (Delta Variant) InfectionMohanad M Al-Obaidi, Ahmet B Gungor, Saman Nematollahi, et al.
Kidney International Reports|January 16, 2026
Predicting Simultaneous Heart Kidney Allocation and Posttransplant Adverse Kidney OutcomesMutlu Mete, Mehmet U S Ayvaci, Ahmet B Gungor, et al.
Pageof 2